C3.ai, Inc.
| Company Name | C3.ai, Inc. |
| Stock Symbol | AI |
| Class Period | February 26, 2025 to August 08, 2025 |
| Lead Plaintiff Motion Deadline | October 21, 2025 |
On August 8, 2025, C3.ai released disappointing preliminary financial results for the first quarter of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, citing “the reorganization with new leadership” and the health ailments of its CEO.
On this news, C3.ai’s stock price fell $5.66, or 25.6%, to close at $16.47 per share on August 11, 2025, thereby injuring investors.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) C3.ai’s optimistic reports of growth, earnings potential, and anticipated margins fell short of reality as they relied far too heavily on the health and effectiveness of the Company’s CEO; (2) Despite repeated assurances, the Company’s CEO had not sufficiently recovered from his ailments to act in the same capacity for C3.ai as he had previously; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Submit Your Information
If you suffered a loss on your C3.ai, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.